Viking Global Investors’s 4D Molecular Therapeutics FDMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,934,914
| Closed | -$61.6M | – | 91 |
|
|
2024
Q2 | $61.6M | Hold |
2,934,914
| – | – | 0.24% | 66 |
|
|
2024
Q1 | $93.5M | Sell |
2,934,914
-1,853,000
| -39% | -$59M | 0.35% | 56 |
|
|
2023
Q4 | $97M | Hold |
4,787,914
| – | – | 0.36% | 56 |
|
|
2023
Q3 | $61M | Hold |
4,787,914
| – | – | 0.25% | 60 |
|
|
2023
Q2 | $86.5M | Buy |
4,787,914
+850,000
| +22% | +$15.4M | 0.35% | 57 |
|
|
2023
Q1 | $67.7M | Hold |
3,937,914
| – | – | 0.32% | 56 |
|
|
2022
Q4 | $87.5M | Hold |
3,937,914
| – | – | 0.44% | 50 |
|
|
2022
Q3 | $31.7M | Hold |
3,937,914
| – | – | 0.15% | 74 |
|
|
2022
Q2 | $27.5M | Hold |
3,937,914
| – | – | 0.13% | 75 |
|
|
2022
Q1 | $59.5M | Hold |
3,937,914
| – | – | 0.24% | 73 |
|
|
2021
Q4 | $86.4M | Hold |
3,937,914
| – | – | 0.25% | 75 |
|
|
2021
Q3 | $106M | Hold |
3,937,914
| – | – | 0.29% | 69 |
|
|
2021
Q2 | $94.8M | Hold |
3,937,914
| – | – | 0.29% | 64 |
|
|
2021
Q1 | $171M | Hold |
3,937,914
| – | – | 0.51% | 52 |
|
|
2020
Q4 | $163M | Buy |
+3,937,914
| New | +$163M | 0.45% | 56 |
|